~~<i id='2644419E1E'><strike id='2644419E1E'><tt id='2644419E1E'><pre id='2644419E1E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：comprehensive 2025-09-04 02:32:57 - browse：6612

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Where are patients getting their prescriptions for GLP

knowledge

leisure time

hotspot

explore

focus

explore

ChristineKao/STATUnitedHealthGroupquietlyacquireddozensofoutpatientfacilitiesin2023,withaparticularf

WSS

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

What it’s like to watch children die of measles

With psoriasis trial ahead, Alumis raises $259 million

Who are the detained American citizens released from prison in Iran?

Maui funeral service workers on devastation of fires: 'I'm in shock'

Wikipedia

leisure time

knowledge

Virginia high school admissions case could be legal follow

How to bring more disabled researchers into academia

Continuity nursing helped my family in our darkest PICU moments

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Peter Hotez and the public health issue of online harassment

TB outbreak tied to bone grafts underscores testing shortcomings

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Maui funeral service workers on devastation of fires: 'I'm in shock'

Apple is now the first public company to be valued at $3 trillion

Precocious puberty in girls comes with mental health risks

leisure time

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Pharma budget tightening trickles down to Doximity

GOP presidential candidates start declaring their loyalty

Where are patients getting their prescriptions for GLP

IVF, abortion rights issues kick off Biden’s State of the Union

hotspot

explore

focus

explore